Biotech & Biopharmaceutical Manufacturing Insurance

CALL FOR EXPERT ADVICE
GET A QUOTE

Specialist cover for biologics, vaccines, CDMOs, cell & gene therapy facilities, and GMP manufacturers — protecting batches, cleanrooms, equipment, contracts and liabilities.

CALL FOR EXPERT ADVICE
GET A QUOTE

We compare quotes from leading insurers

  • Allianz
  • Aviva
  • QBE
  • RSA
  • Zurich
  • NIG

BIOTECH INSURANCE THAT HELPS YOU SCALE SAFELY

Why Biotech & Biopharmaceutical Manufacturing Insurance Matters

Biopharmaceutical manufacturing combines high-value inputs, complex processing, strict GMP controls, and intense regulatory scrutiny. One deviation can mean scrapped batches, delayed release, contractual penalties, and reputational harm. Whether you manufacture monoclonal antibodies, vaccines, recombinant proteins, viral vectors, plasmids, or advanced therapies, you face a unique combination of risks that standard manufacturing insurance often fails to address.

Insure24 arranges insurance programmes specifically for biotech and biopharma manufacturers — including companies producing clinical trial materials, commercial biologics, biosimilars, and sterile fill-finish products. We help you protect your site, people, equipment, R&D work, batch integrity, supply chain obligations, and liabilities worldwide.

Biotech Manufacturing Risks Are Different

Traditional pharma manufacturing is often based on chemical synthesis and relatively stable raw materials. Biotech production, by contrast, relies on living systems, highly sensitive upstream/downstream processing, sterile environments, and cold-chain handling. That means risk is amplified across the entire lifecycle — from cell banks and seed train integrity to purification yields, fill-finish sterility, and validated storage conditions.

A minor incident — a HEPA failure, a sterile barrier breach, an out-of-spec reading, an unplanned shutdown, a temperature excursion, or a supplier contamination event — can turn into a major loss. Insure24 helps you build cover that reflects how biotech facilities actually operate, not a generic “factory” approach.

  • Contamination & sterility events – microbial contamination, endotoxins, cross-contamination, sterility failure, and cleaning validation issues.
  • Batch failure / yield loss – upstream failures, purification issues, filtration breaches, and process deviation leading to batch disposal.
  • Cold-chain breakdown – fridge/freezer/cryogenic failure, power interruption, alarm failure, logistics delay, or mishandling.
  • Regulatory action – GMP observations, manufacturing suspension, batch rejection, recall, or enforced corrective actions.
  • High-value equipment dependency – bioreactors, centrifuges, autoclaves, isolators, LAF cabinets, chromatography skids, clean steam systems.
  • Contractual exposure – CDMO service level obligations, delivery deadlines, quality agreements, and penalties for delay.
CALL FOR EXPERT ADVICE
GET A QUOTE

What Biotech & Biopharma Manufacturing Insurance Can Cover

Your insurance programme should map to your real exposure: where value is created (and where it can be destroyed). That includes your premises, cleanroom infrastructure, equipment, materials in process, finished stock, contractual obligations, and third-party liabilities — including international exposure if you export or supply global trials.

Liability Covers

  • Product Liability – claims arising from injury or property damage caused by your products, including alleged defects, contamination or labelling errors.
  • Public Liability – third-party injury or damage claims arising from your premises or operations.
  • Employers’ Liability – mandatory UK cover for employee injury/illness claims arising from their work.
  • Clinical Trials Liability – protection for trial-related injury claims and investigational product exposures, where applicable.
  • Completed Operations – claims after a product has left your control, especially relevant for sterile and injectable products.
  • Worldwide / USA & Canada Extensions – where you export, supply global trials or sell into higher-litigation territories.

For biotech manufacturers, liability is not just about what you make — it’s also about how you make it. Claims can arise from alleged contamination, deviation, stability issues, traceability gaps, or supply chain integrity failures. We help structure liability limits and wording to match your distribution model and risk profile.

Property, Batch & Operational Covers

  • Buildings & Contents – protection for premises, office and lab contents, and specialist fit-out.
  • Cleanroom & Critical Utilities – cover for HVAC, HEPA systems, pressure control, clean steam, WFI, compressed air, and monitoring systems.
  • Machinery Breakdown – sudden mechanical/electrical failure of key equipment such as chillers, bioreactors, autoclaves, skids and freezers.
  • Stock / Batch Insurance – finished stock and work-in-progress, including high-value batches and materials.
  • Deterioration of Stock – loss of stock due to temperature excursion from power failure or refrigeration breakdown.
  • Business Interruption – lost gross profit and increased costs following an insured event that halts production.

Because biologics are often temperature sensitive and time critical, stock cover must consider not only the value of finished goods but also the value of work-in-progress (WIP), raw materials, cell banks, and the cost of re-running production cycles. We’ll help you identify how batch values accumulate across upstream and downstream stages so you aren’t underinsured at the worst moment.

CALL FOR EXPERT ADVICE
GET A QUOTE

Common Causes of Loss in Biopharmaceutical Manufacturing

Insurance works best when it’s built around realistic scenarios. Below are the types of incidents that regularly create severe financial impact for biotech and biopharma manufacturers — even where safety systems and GMP processes are strong.

Contamination & Batch Rejection

Contamination events are one of the most costly exposures for biologics manufacturers. A single breach can compromise an entire batch, require extended downtime for investigation and remediation, and trigger recall or notification obligations if any material has shipped.

  • Microbial contamination (bacteria, fungi, mycoplasma)
  • Endotoxin issues / pyrogenicity concerns
  • Cross-contamination between products or campaigns
  • Sterile fill-finish deviations
  • Cleaning validation failure or operator error

Good manufacturing systems reduce frequency, but they don’t eliminate risk — and the impact can still be extreme due to batch value and time-to-replace constraints.

Equipment Failure & Utilities

Biotech manufacturing is equipment-dependent. If critical systems fail, production stops — and WIP can be lost. Machinery breakdown cover is often the difference between a manageable incident and a multi-month crisis.

  • Chiller or HVAC failure affecting cleanroom stability
  • Autoclave failure affecting sterilisation cycles
  • Bioreactor control failure leading to lost culture
  • Freezer or cryostorage failure causing stock loss
  • Power failure and alarm/monitoring breakdown

We’ll help ensure your policy reflects the true cost of breakdown: repair, lost product, downtime, expedited shipping, and overtime to recover schedules.

Temperature Excursion & Cold Chain

Even short temperature excursions can render biologics and vaccines unusable. Some products have tight excursion allowances and require documented evidence for release. When storage conditions cannot be proven, stock may be rejected even if it appears unaffected.

  • Refrigeration breakdown at site
  • Power outage affecting cold rooms or freezers
  • Logistics delay, customs hold or courier mishandling
  • Data logger failure or missing temperature records
  • Cryogenic supply failure for advanced therapies

Stock deterioration and transit cover can be structured to protect both stored inventory and goods in transit — including high-value trial material shipments.

Regulatory & Recall Exposure

Regulatory actions can create direct costs (investigation, response, recall logistics) and indirect costs (downtime, lost contracts, reputational impact). For manufacturers supplying clinical trials or hospitals, rapid and accurate response is crucial.

  • GMP observations leading to stop-production
  • Batch release hold or rejection
  • Market recall / withdrawal and notification
  • Corrective and preventive action (CAPA) cost pressures
  • Contract penalties for missed supply milestones

Product recall insurance can help with the operational and communication costs that often arrive at the worst possible time — when your team is already under pressure.

CALL FOR EXPERT ADVICE
GET A QUOTE
Quote icon

A refrigeration fault put a high-value batch at risk. Insure24 helped us structure cover for stock deterioration and business interruption, so the incident didn’t derail our delivery schedule.

Operations Lead, UK Biopharma Manufacturer

UNIQUE INSURANCE
TAILORED FOR YOU 

PROTECT YOUR FACILITY

  • Cleanrooms, GMP suites, laboratories and controlled environments
  • Specialist equipment and critical utilities
  • Materials in process, finished biologics, and trial stock
  • Cold storage, cryogenic systems, and validated monitoring
  • Business interruption caused by insured events and breakdown

If you operate multiple sites, shared clean utilities, or campaign manufacturing schedules, we can structure cover that reflects your operational model — including key supplier dependency and contract manufacturing exposure.

PROTECT YOUR BUSINESS

  • Third-party injury and damage claims arising from products
  • Recall and withdrawal costs, including logistics and notification
  • Contractual obligations and service delivery exposures (CDMOs)
  • Errors, deviations, and operational incidents affecting output
  • Claims defence costs and specialist incident support where available

A good insurance programme should do two things: protect your balance sheet and support operational continuity. We focus on cover that fits your stage — from R&D and clinical supply through to commercial-scale manufacturing.

CALL FOR EXPERT ADVICE
GET A QUOTE

Compliance & Regulations in Biopharmaceutical Manufacturing

Insurance can’t replace GMP, quality systems, or regulatory compliance — but it can protect you when something goes wrong despite robust controls. Biotech manufacturers typically operate under tight regulatory frameworks and customer audits. Your insurer will often expect evidence of good practice: documented SOPs, validated processes, traceability, deviation management, and security around high-value biologic materials.

Our approach is to help you present your risk profile clearly to insurers, which can improve terms and reduce delays in quoting. Key compliance areas commonly considered include:

  • GMP manufacturing controls and batch documentation
  • Validation of cleanrooms, sterilisation, and environmental monitoring
  • Cold chain controls and alarm/monitoring resilience
  • Supplier qualification and incoming material checks
  • Deviation/CAPA procedures and audit readiness
  • Traceability, labelling, and release processes
  • Security and access control for high-value stock

How insurance supports continuity

When an incident happens, the financial pressure often arrives immediately: investigation costs, specialist engineers, disposal, expedited shipping, overtime labour, and replacement materials. Depending on cover, insurance can help fund recovery so the business can focus on restoring compliant operations.

For CDMOs, continuity is also about protecting relationships and delivery commitments. With the right business interruption and operational covers in place, you can reduce the risk that a single event becomes a long-term commercial setback.

CALL FOR EXPERT ADVICE
GET A QUOTE

How to Get Biotech & Biopharmaceutical Manufacturing Insurance

Getting the right insurance shouldn’t slow your operations down. The goal is a clear, specialist proposal that reflects your processes and helps insurers quote accurately. If you’re early stage, we can still arrange cover — and help you build an insurance roadmap as you scale into commercial manufacturing.

  • 1. Share your activities – what you manufacture, where you sell/supply, and whether you produce clinical trial material or commercial stock.
  • 2. Identify batch values – peak values for WIP, finished stock, and temperature-sensitive inventory.
  • 3. Review operational controls – GMP status, cleanroom validation, monitoring, maintenance, and quality systems.
  • 4. Build a tailored programme – select cover sections, limits, extensions, and wording that fit your risk profile.
  • 5. Bind and stay supported – ongoing advice, mid-term adjustments, and renewal strategy as you grow.

If you’re a CDMO, we’ll also consider client contract terms, indemnities, and the balance between your own liability and the sponsor’s responsibilities.

Information that speeds up quoting

  • Turnover (or forecast), headcount, and locations
  • Product types: biologics, vaccines, APIs, vectors, ATMPs
  • Distribution: UK, EU, worldwide, USA/Canada exposure
  • GMP status and audit history (high level)
  • Cold storage details and monitoring systems
  • Peak stock/batch values and key dependencies
  • Claims history (if any)

Don’t worry if you don’t have everything. We can start with the essentials and refine as needed — especially for early-stage organisations.

CALL FOR EXPERT ADVICE
GET A QUOTE

FREQUENTLY ASKED QUESTIONS

+-

What is biotech & biopharmaceutical manufacturing insurance?

Biotech & biopharmaceutical manufacturing insurance is a specialist business insurance programme designed for companies that develop or manufacture biologics, vaccines, advanced therapies, clinical trial materials, and other life science products. It typically combines core covers like Employers’ Liability, Public Liability and Product Liability with specialist sections such as stock deterioration (cold chain), machinery breakdown, business interruption, and product recall. The aim is to protect your facility, your batches, and your liabilities — so one incident doesn’t become a company-threatening loss.

+-

Do biotech manufacturers need Product Liability insurance?

In most cases, yes. If you supply materials or finished products that could cause injury or property damage, Product Liability cover is essential. Even if you primarily manufacture for clinical trials or supply sponsors as a CDMO, contractual requirements often mandate Product Liability insurance. The right limit depends on your products, territories (for example, USA/Canada exposure), distribution chain, and risk profile.

+-

Does insurance cover batch contamination or sterility failure?

Coverage depends on the policy wording and the cause of loss. Some policies can cover resulting losses under stock/batch sections, machinery breakdown (where equipment failure is the trigger), or business interruption following an insured incident. Product recall insurance can help when contaminated product has shipped or requires withdrawal. Not every policy automatically includes contamination/batch failure as a trigger — so it’s important to structure cover specifically for biotech manufacturing realities.

+-

What is stock deterioration (cold chain) insurance?

Stock deterioration insurance (sometimes called deterioration of stock) covers loss of stock caused by temperature change — commonly due to refrigeration breakdown or power failure. This is especially important for biologics, vaccines, and advanced therapies that require validated storage conditions. Policies can also be extended to address goods in transit where appropriate, including high-value clinical trial shipments.

+-

Can early-stage biotech companies get manufacturing insurance?

Yes. Even if you are pre-revenue, grant-funded or VC-backed, you may still need cover for lab premises, employees, third-party liability, and contractual obligations — particularly if you work with partners, CROs/CDMOs, or supply trial material. We can structure insurance that matches your stage, with the ability to scale limits and sections as you move into larger facilities or commercial production.

+-

What information do I need to get a quote?

Typically you’ll need basic company information (turnover or forecast, headcount, locations), an outline of what you manufacture (biologics, vaccines, vectors, etc.), where you supply (UK/EU/worldwide), GMP status, and your approximate peak batch/stock values. Details on cold storage, monitoring, and key equipment also help. If you don’t have everything, we can start with a high-level view and refine as we go.
CALL FOR EXPERT ADVICE
GET A QUOTE

Related Blogs